| Title: | UK Biobank Whole-Exome Sequence Binary Phenome Analysis with Robust Region-Based Rare-Variant Test |
| Journal: | American Journal of Human Genetics |
| Published: | 19 Dec 2019 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/31866045/ |
| DOI: | https://doi.org/10.1016/j.ajhg.2019.11.012 |
| URL: | http://www.cell.com/article/S0002929719304331/pdf |
| Citations: | 61 (26 in last 2 years) as of 8 Aug 2024 |
Publication 5934
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
In biobank data analysis, most binary phenotypes have unbalanced case-control ratios, and this can cause inflation of type I error rates. Recently, a saddle point approximation (SPA) based single-variant test has been developed to provide an accurate and scalable method to test for associations of such phenotypes. For gene- or region-based multiple-variant tests, a few methods exist that can adjust for unbalanced case-control ratios; however, these methods are either less accurate when case-control ratios are extremely unbalanced or not scalable for large data analyses. To address these problems, we propose SKAT- and SKAT-O- type region-based tests; in these tests, the single-variant score statistic is calibrated based on SPA and efficient resampling (ER). Through simulation studies, we show that the proposed method provides well-calibrated p values. In contrast, when the case-control ratio is 1:99, the unadjusted approach has greatly inflated type I error rates (90 times that of exome-wide sequencing α = 2.5 × 10-6). Additionally, the proposed method has similar computation time to the unadjusted approaches and is scalable for large sample data. In our application, the UK Biobank whole-exome sequence data analysis of 45,596 unrelated European samples and 791 PheCode phenotypes identified 10 rare-variant associations with p value < 10-7, including the associations between JAK2 and myeloproliferative disease, HOXB13 and cancer of prostate, and F11 and congenital coagulation defects. All analysis summary results are publicly available through a web-based visual server, and this availability can help facilitate the identification of the genetic basis of complex diseases.</p>
6 Authors
- Zhangchen Zhao
- Wenjian Bi
- Wei Zhou
- Peter VandeHaar
- Lars G Fritsche
- Seunggeun Lee
Enabling scientific discoveries that improve human health